1-19 of 19
Walter Hanel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final Results of a Phase 2, Single Arm Trial Evaluating Letermovir for Cytomegalovirus Prophylaxis in Patients with Hematological Malignancies Treated with Alemtuzumab

John C. Reneau, Ying Huang, Walter Hanel, Catherine Chung, Jonathan E. Brammer, Basem William
Journal: Blood
Blood (2024) 144 (Supplement 1): 6390.
https://doi.org/10.1182/blood-2024-201307
Published: 2024
Journal Articles

Patterns of Use and Outcomes of Novel Agents in Patients with Relapsed or Refractory Large B-Cell Lymphoma: A Single-Center Retrospective Analysis

Sonia Godbole, Rina Li Welkie, Audrey M. Sigmund, Timothy Voorhees, Walter Hanel, David A. Bond, John C. Reneau, Lapo Alinari, Jonathan E. Brammer, Beth Christian, Robert Baiocchi, Kami J. Maddocks, Yazeed Sawalha
Journal: Blood
Blood (2024) 144 (Supplement 1): 4460.
https://doi.org/10.1182/blood-2024-207738
Published: 2024
Journal Articles

Targeting PRMT5-Mediated DNA Repair Pathway in Extra-Nodal NK/T-Cell Lymphoma (ENKTL)

Youssef Youssef, Walter Hanel, Wing Chan, Fiona C. Brown, Claire Hinterschied, Jobeth Helmig-Mason, Neha Bhagwat, Kris Vaddi, Peggy A Scherle, Amin Noorani, Sr., Aharon G. Freud, Lapo Alinari, Christopher C. Oakes, Bethany L. Mundy-Bosse, Robert Baiocchi
Journal: Blood
Blood (2024) 144 (Supplement 1): 5848.
https://doi.org/10.1182/blood-2024-201980
Published: 2024
Journal Articles

Final Results of a Phase II Study of Brentuximab Vedotin and Lenalidomide in Relapsed and Refractory T-Cell Lymphomas

John C. Reneau, Ying Huang, Walter Hanel, Jonathan E. Brammer, Catherine Chung, Basem William
Journal: Blood
Blood (2024) 144 (Supplement 1): 4438.
https://doi.org/10.1182/blood-2024-201294
Published: 2024
Journal Articles

Nivolumab in Combination with Dose Adjusted (DA) R-EPOCH for First-Line Treatment of Large B-Cell Lymphoma: Results from a Phase II Trial

David A. Bond, Ying Huang, John C. Reneau, Yazeed Sawalha, Jonathan E. Brammer, Timothy Voorhees, Narendranath Epperla, Audrey M. Sigmund, Lapo Alinari, Walter Hanel, Anna Gilmore, Misty Fleming, Kathleen Stamper, Robert Baiocchi, Beth Christian, Kami J. Maddocks
Journal: Blood
Blood (2024) 144 (Supplement 1): 1719.
https://doi.org/10.1182/blood-2024-194545
Published: 2024
Journal Articles

Acute Kidney Injury Following Chimeric Antigen Receptor T-Cell Therapy Is Associated with Inferior Survival for Patients with Relapsed or Refractory Large B-Cell Lymphoma

John Sharp, Qiuhong Zhao, Timothy Voorhees, David A. Bond, Yazeed Sawalha, John C. Reneau, Audrey M. Sigmund, Walter Hanel, Lalit Sehgal, Lapo Alinari, Robert Baiocchi, Jonathan E. Brammer, Kami J. Maddocks, Beth Christian, Evandro Bezerra, Nathan Denlinger, Sumithira Vasu, Marcos de Lima, Jason Prosek, Narendranath Epperla
Journal: Blood
Blood (2024) 144 (Supplement 1): 3747.
https://doi.org/10.1182/blood-2024-203798
Published: 2024
Journal Articles

Targeting the DNA Damage Response through TBL1X in Mantle Cell Lymphoma

Betsy A Pray, Ethan Baiocchi, Sydney Leon, Brian Barta, Shirsha Koirala, Wing Chan, Walter Hanel, Lalit Sehgal, Robert Baiocchi, Lapo Alinari
Journal: Blood
Blood (2024) 144 (Supplement 1): 1403.
https://doi.org/10.1182/blood-2024-207407
Published: 2024
Journal Articles

Steroid Prophylaxis in Patients Receiving CAR T-Cell Therapy for Relapsed and Refractory Non-Hodgkin Lymphoma

Jacob Butman, Alma Habib, Rina Li Welkie, Yazeed Sawalha, Audrey M. Sigmund, Beth Christian, Kami J. Maddocks, Walter Hanel, David A. Bond, Lapo Alinari, Robert Baiocchi, Hannah Choe, John C. Reneau, Gabriela Sanchez-Petitto, Jonathan E. Brammer, Evandro Bezerra, Timothy Voorhees, Sumithira Vasu, Sarah A. Wall, Marcos de Lima, Nathan Denlinger
Journal: Blood
Blood (2024) 144 (Supplement 1): 4507.
https://doi.org/10.1182/blood-2024-206559
Published: 2024
Journal Articles

Gemcitabine and Liposomal Doxorubicin (GemDox) for the Treatment of Relapsed and Refractory T-Cell Lymphomas

Zachary Braunstein, Allyson Waller, Emily Dotson, Eric McLaughlin, Walter Hanel, John C Reneau, Daniel Addison, Pierluigi Porcu, Jonathan E. Brammer
Journal: Blood
Blood (2023) 142 (Supplement 1): 4453.
https://doi.org/10.1182/blood-2023-184583
Published: 2023
Journal Articles

Zanubrutinib in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): Interim Results from a Phase 1b Clinical Trial

Yazeed Sawalha, Rina Li Welkie, Anna Krivenko, Brian Hess, Audrey M. Sigmund, Timothy Voorhees, Walter Hanel, David A. Bond, John C Reneau, Narendranath Epperla, Lapo Alinari, Jonathan E. Brammer, Beth Christian, Robert Baiocchi, Kami J. Maddocks
Journal: Blood
Blood (2023) 142 (Supplement 1): 6226.
https://doi.org/10.1182/blood-2023-182941
Published: 2023
Journal Articles

PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma

Shelby L. Sloan, Fiona Brown, Mackenzie Long, Christoph Weigel, Shirsha Koirala, Ji-Hyun Chung, Betsy Pray, Lynda Villagomez, Claire Hinterschied, Anuvrat Sircar, JoBeth Helmig-Mason, Alexander Prouty, Eric Brooks, Youssef Youssef, Walter Hanel, Samir Parekh, Wing Keung Chan, Zhengming Chen, Rosa Lapalombella, Lalit Sehgal, Kris Vaddi, Peggy Scherle, Selina Chen-Kiang, Maurizio Di Liberto, Olivier Elemento, Cem Meydan, Jonathan Foox, Daniel Butler, Christopher E. Mason, Robert A. Baiocchi, Lapo Alinari
Journal: Blood
Blood (2023) 142 (10): 887–902.
https://doi.org/10.1182/blood.2022019419
Published: 2023
Includes: Supplemental data
Journal Articles

Nanochip Technology for Monitoring Chemotherapy Response Using Extracellular RNAs and Proteins in Patient Plasma with Diffuse Large B-Cell Lymphoma As Biomarkers

Narendranath Epperla, Xinyu Wang, Hong Li, David A. Bond, Yazeed Sawalha, John C. Reneau, Timothy J. Voorhees, Kami J. Maddocks, Beth Christian, Walter Hanel, Lapo Alinari, Lalit Sehgal, Robert A. Baiocchi, James L. Lee
Journal: Blood
Blood (2022) 140 (Supplement 1): 11873–11875.
https://doi.org/10.1182/blood-2022-164907
Published: 2022
Journal Articles

Impact of Circulating Lymphoma at Diagnosis on Outcomes in Patients with Marginal Zone Lymphoma

Kaitlin Annunzio, Natalie S. Grover, Rui Li, Daniel Jones, Walter Hanel, Beth Christian, Adam J. Olszewski, Narendranath Epperla
Journal: Blood
Blood (2022) 140 (Supplement 1): 3644–3645.
https://doi.org/10.1182/blood-2022-164892
Published: 2022
Journal Articles

Impact of Circulating Lymphoma at Diagnosis on Outcomes in Patients with Diffuse Large B-Cell Lymphoma

Srichandhana Rajamouli, Eric McLaughlin, Walter Hanel, David A. Bond, Yazeed Sawalha, Timothy J. Voorhees, Lapo Alinari, Lalit Sehgal, Kami J. Maddocks, Beth Christian, Daniel Jones, Narendranath Epperla
Journal: Blood
Blood (2022) 140 (Supplement 1): 6659–6660.
https://doi.org/10.1182/blood-2022-166988
Published: 2022
Journal Articles

PRMT5 Inhibition Modulates E2F1 and P53 to Restore Cell Cycle Regulation and Drive DNA Damage Response in Ibrutinib-Resistant Mantle Cell Lymphoma

Shelby Sloan, Fiona Brown, Mackenzie Long, JoBeth Helmig-Mason, Stacey Beck, Ji Hyun Chung, Walter Hanel, Eric Brooks, Haley Klimazewski, Cem Meydan, Jonathan Foox, Daniel Butler, John C. Byrd, Rosa Lapalombella, Maurizio Di Liberto, Christopher Mason, Selina Chen-Kiang, Kris Vaddi, Peggy Scherle, Robert Baiocchi, Lapo Alinari
Journal: Blood
Blood (2021) 138 (Supplement 1): 787.
https://doi.org/10.1182/blood-2021-153992
Published: 2021
Journal Articles

A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma

Walter Hanel, MD, Beth A. Christian, MD, Kami J. Maddocks, MD, Narendranath Epperla, MDMS, Basem M. William, MDMRCP, Samantha Jaglowski, MD MPH, David A. Bond, MD, Yazeed Sawalha, MD, John C. Reneau, MDPhD, Jonathan E Brammer, MD, Robert Baiocchi, MD PhD, Kristie A. Blum, MD, Lapo Alinari, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29.
https://doi.org/10.1182/blood-2020-141243
Published: 2020
Journal Articles

Outcomes of Patients with Limited-Stage Plasmablastic Lymphoma

Brian T. Hess, MD, Anshu Giri, MD, Yeonhee Park, PhD, Krina K. Patel, MD, Brian K. Link, MD, Grzegorz S. Nowakowski, MD, Seth M Maliske, MD, Sonia Fortin, Julio C. Chavez, MD, Hayder Saeed, MD, Brian T. Hill, MD, Alex V. Mejia Garcia, MD, Kami J. Maddocks, MD, Walter Hanel, MD, Nina D. Wagner-Johnston, Marcus Raymond Messmer, MD, Brad S. Kahl, MD, Marcus Watkins, PhD, Juan Pablo Alderuccio, MD, Izidore S. Lossos, MD, Sunita Nathan, MD, Victor M. Orellana-Noia, MD, Craig A. Portell, MD, Daniel J. Landsburg, MD, Emily C. Ayers, MD, Jorge J. Castillo, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-138536
Published: 2020
Journal Articles

Targeting Hypersumoylation in Mantle Cell Lymphoma

Walter Hanel, MD PhD, Liudmyla Tsyba, PhD, Dennis Huszar, PhD, Alex Prouty, Xiaoli Zhang, PhD, JoBeth Helmig-Mason, Msc, Bethany L Mundy-Bosse, PhD, Youssef Youssef, MD, Samir Parekh, MD, Kami J. Maddocks, MD, Robert A Baiocchi, MD PhD, Lapo Alinari, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4060.
https://doi.org/10.1182/blood-2019-127363
Published: 2019
Journal Articles

Impact of Novel Agents on Outcomes of Patients with Classical Hodgkin Lymphoma and Primary Treatment Failure

Narendranath Epperla, MDMS, Luciano J. Costa, MD PhD, John L Vaughn, MD, Walter Hanel, MD PhD, Saba Raya, MD, Amanda F Cashen, MD, Rehan Sarmad, MD MBBS, Talha Badar, MD, Mehdi Hamadani, MD, Yang Liu, MD, Stefan K. Barta, MD MRCP, MS, Paolo Caimi, MD, Tarsheen K. Sethi, MD, Nishitha Reddy, MD, Madelyn Burkart, MD, Reem Karmali, MD, Celeste Bello, MD, Julio C. Chavez, MD, Shalin K. Kothari, MD, Francisco J. Hernandez-Ilizaliturri, MD, Hatcher J. Ballard, BS, Jakub Svoboda, MD, Lukas Emery, DO, Frederick Lansigan, MD, Martha Glenn, MD, Michael C. Churnetski, Jonathon B. Cohen, MDMS, Caryn Sorge, MD, Ana C. Xavier, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1554.
https://doi.org/10.1182/blood-2019-129199
Published: 2019